DBV Technologies Begins Phase 3 Safety Study for Viaskin Peanut Patch in Peanut-Allergic Toddlers

DBV Technologies announced the first subject has been screened in its COMFORT Toddlers study, a Phase 3 supplemental safety study evaluating the Viask...
Home/KnloSights/Clinical Trial Updates/DBV Technologies Begins Phase 3 Safety Study for Viaskin Peanut Patch in Peanut-Allergic Toddlers